UNSPSC 51286502: Mupirocin calcium

This classification denotes a topical anti-infective agent with the molecular structure 2C26H43O9.CA.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, RG38I2P540 chemically known as (.alpha.e,2s,3r,4r,5s)-5-((2s,3s,4s,5s)-2,3-epoxy-5-hydroxy-4-methylhexyl)tetrahydro-3,4-dihydroxy-.beta.-methyl-2h-pyran-2-crotonic acid, ester with 9-hydroxynonanoic acid, calcium salt (2:1), dihydrate, but more commonly known as mupirocin calcium, which bears US NIH Compound Identifier 5282317.

European Medicines Agency schedules Mupirocin calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14612MIG.

UNSPSC 51286502 Mupirocin calcium is a Commodity code that does not align with state and local procurement activity shown in recent opportunities. The code nominally describes a single pharmaceutical product—mupirocin calcium, a topical antibiotic ointment—yet the recent solicitations tagged under this code concern naloxone procurement, direct-to-manufacturer pharmacy programs, emergency medical supplies for fire departments, and generic multi-source pharmaceuticals and OTC products. These opportunities span emergency response, community health, and broad-based pharmacy benefit management, none of which center on mupirocin calcium or single-product pharmaceutical commodities. The issuing bodies include county health departments (Seminole County, Florida), state HHS commissions (Texas), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The geographic spread covers Florida, Texas, Minnesota, and Oregon, reflecting both direct state and local procurement and cooperative purchasing vehicle activity.

The recent opportunities show minimal relevance to mupirocin calcium as a discrete procurement target. Seminole County's IFB 60459723LAS (posted June 30, 2026; due July 26, 2023) solicited naloxone and drug deactivation systems in large volumes for community health delivery. Texas HHS issued RFI HHS0017013 (posted April 3, 2026) to explore direct-to-manufacturer prescription fulfillment models outside traditional PBM channels. The City of Tampa's IFB 26P00145 (posted March 25, 2026; due March 13, 2026) sought 169 line items of medical and first-aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000.00 and SLBE set-aside eligibility. MMCAP's RFP S1070000015802 (posted January 20, 2026; due March 26, 2026) requested generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with contract awards effective July 1, 2026. The code shows little relevant recent activity and appears to be a tagging mismatch in the data.